AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
70.22
+1.49 (2.17%)
At close: Apr 14, 2026, 4:00 PM EDT
70.22
0.00 (0.00%)
After-hours: Apr 14, 2026, 5:37 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $2.02 billion as of April 14, 2026. Its market cap has increased by 252.98% in one year.
Market Cap
2.02B
Enterprise Value
1.99B
1-Year Change
252.98%
Ranking
Category
Stock Price
$70.22
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $2.02B, an increase of 553.94%. That is a compound annual growth rate of 22.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 1.98B | 47.20% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 2.16B |
| Definium Therapeutics | 2.15B |
| Aurinia Pharmaceuticals | 2.10B |
| Stoke Therapeutics | 2.03B |
| Adaptive Biotechnologies | 1.97B |
| Mesoblast | 1.94B |
| Zymeworks | 1.94B |
| Agios Pharmaceuticals | 1.93B |